dc.contributor.author |
Rupenthal, Ilva |
en |
dc.contributor.author |
Alany, Raid |
en |
dc.date.accessioned |
2011-12-21T01:10:39Z |
en |
dc.date.issued |
2007 |
en |
dc.identifier.citation |
Controlled Release Society Newsletter 24(2):12-14 2007 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/10264 |
en |
dc.description.abstract |
Since the late 1970s antisense oligonucleotides (AsONs) have been investigated as powerful tools for selective regulation of gene expression. Antisense drugs act by specifically binding to the target mRNA, which results in inhibition of their translation into a protein. They have already been proven efficient for the treatment of various viral infections, such as human immunodeficiency virus (HIV) type 1, hepatitis B virus, and human cytomegalovirus (CMV), and are also believed to be valuable candidates for cancer treatment. ... |
en |
dc.publisher |
Controlled Release Society |
en |
dc.relation.ispartofseries |
Controlled Release Society Newsletter |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.title |
Fluorescence resonance energy transfer - A new tool to quantify the stability of antisense oligonucleotides |
en |
dc.type |
Journal Article |
en |
pubs.issue |
2 |
en |
pubs.begin-page |
12 |
en |
pubs.volume |
24 |
en |
dc.rights.holder |
Copyright: 2007 Controlled Release Society |
en |
pubs.author-url |
http://www.controlledreleasesociety.org/publications/Newsletter/Documents/v24i2.pdf |
en |
pubs.end-page |
14 |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/RestrictedAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
75540 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Ophthalmology Department |
en |
pubs.record-created-at-source-date |
2010-09-01 |
en |